Biotech Investors & VC Firms in Norway
37 firms in this list, with a median first check of $540K. 12 of them lead rounds. Generated from verified public data and updated continuously.
CapMan
HelsinkiGrowth–Late Stage$2.2M – $64.8M
19 people
Nordic Capital
StockholmGrowth–Late Stage
13 people
Nordic Foodtech VC
HelsinkiPre-Seed–Series A$540K – $2.2M
9 people
EIR Ventures
StockholmSeed–Series A
10 people
Nordic Science Investments
HelsinkiPre-Seed–Seed$55K – $3.9M
7 people
Aescap Life Sciences
AmsterdamSeries A–Growth
14 people
Ventac Partners
Gentofte
12 people
Curitas Ventures
StockholmSeed–Growth
5 people
Vesalius Biocapital III Partners SàRL
ConternSeries B–Late Stage$10.8M
11 people
Alpina Partners
MunichGrowth$635K – $2.5M
3 people
MedCap AB
StockholmSeed–Series A
3 people
Unconventional Ventures
CopenhagenPre-Seed–Series A
3 people
SEB Greentech Venture Capital
StockholmSeed–Growth$1.1M – $4.3M
4 people
Related lists
Investors & VC Firms in North America (12952)Investors & VC Firms in United States (11990)Investors & VC Firms in Europe (5859)Investors & VC Firms in Global (4787)AI & Machine Learning Investors & VC Firms (4629)Fintech Investors & VC Firms (4588)SaaS Investors & VC Firms (4239)Healthtech Investors & VC Firms (4227)Enterprise Software Investors & VC Firms (4136)Crypto & Web3 Investors & VC Firms (3986)
Data sourced from public filings and firms' own websites — see our methodology.











































